This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

EnteroMedics, Bionovo: Early Volume Plays

( Updated to correct Cell Therapeutics share price.)

NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Thursday's session.

EnteroMedics (ERTM) surged by 52 cents, or 64.2%, to $1.33 in early trading after the company said its Maestro System continues to meet its safety goals, according to data from weight loss, hypertension and diabetes clinical studies. The 50-day average daily volume for is 856,000, according to the Nasdaq.

Atlantic Bancgroup (ATBC) slumped by 55 cents, or 15.5%, to $3 after the company said in a regulatory filing late Wednesday that is has consented to the issuance of a consent order with the Federal Deposit Insurance Corporation and the Florida Office of Financial Regulation. Atlantic Bancgroup said it entered into the consent order without admitting or denying any charges of unsafe or unsound banking practices or violations of law or regulation. The 50-day average daily volume for Atlantic Bancgroup is 4,500.

Cell Therapeutics (CTIC - Get Report) fell by 13 cents, or 9.7%, to $1.21 at the open after the company said it raised $30 million through the sale of preferred stock and warrants. The 50-day average daily volume for Cell Therapeutics is 10.61 million shares.

Bionovo (BNVI) rose by 8 cents, or 12.9%, to 70 cents in early trading after the company announced the publication of their results from its phase 1B clinical trial of Bezielle (BZL101) for metastatic breast cancer in Breast Cancer Research and Treatment. The results show that "Bezielle continues to be safe and well tolerated with clinical evidence of anticancer activity" in a heavily pretreated population of women diagnosed with metastatic breast cancer. The 50-day average daily volume for Bionovo is 1.28 million.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ETRM $1.11 0.00%
CTIC $2.42 1.50%
AAPL $129.16 0.05%
FB $79.46 -0.36%
GOOG $573.97 0.46%

Markets

DOW 18,198.72 -89.91 -0.49%
S&P 500 2,107.97 -9.42 -0.44%
NASDAQ 4,979.90 -28.1960 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs